Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1995
09/12/1995US5449694 (-)-ritodrine, therapeutic compositions and use, and method of preparation
09/12/1995US5449693 Benzene derivatives, their preparation and pharmaceutical compositions in which they are present
09/12/1995US5449692 Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
09/12/1995US5449691 Production of interleukin 2
09/12/1995US5449690 Naphthylethylureas and naphthylethylthioureas
09/12/1995US5449689 Naphthylethylureas and naphthylethylthioureas
09/12/1995US5449688 Nitric oxide synthase inhibitor or scavenger
09/12/1995US5449686 4-phenylcyclohexanone derivatives; inhibit production of tumor necrosis factor and phosphodiesterase V
09/12/1995US5449685 Method and composition for treating HIV-type 1 infections
09/12/1995US5449684 Antitumor agents and viricides
09/12/1995US5449683 Methods of inducing sleep using melatonin
09/12/1995US5449682 Angiotensin II antagonists incorporating a substituted benzyl element
09/12/1995US5449681 Use of disulfonyl methanes for the control of parasites
09/12/1995US5449679 Process and products for reducing biological fluid levels of a lipid soluble waste
09/12/1995US5449678 Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
09/12/1995US5449677 Cyclic benzylamino, benzylamido and benzylimido antipsychotic agents
09/12/1995US5449676 Bronchodilator agents
09/12/1995US5449674 Prostaglandin E2 inhibitors
09/12/1995US5449672 Bactericides
09/12/1995US5449663 L-Glucose
09/12/1995US5449522 Antitumor
09/12/1995US5449521 Supported drugs with increased dissolution rate, and a process for their preparation
09/12/1995US5449520 Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level
09/12/1995US5449474 Low toxicity solvent composition
09/12/1995US5449355 Retrograde tissue splitter and method
09/12/1995US5448898 Air treatment plant for foodstuff comprising a trough with an adjustable width
09/12/1995EP0680318A4 Method for increasing the efficiency of feed conversion in animals.
09/12/1995CA2144390A1 Malonic acid derivatives having antiadhesive properties
09/12/1995CA2144388A1 Carbohydrate mimetics having antiadhesive properties
09/12/1995CA2144288A1 Alkylaminoindans compounds; process for preparing the same and pharmaceutical compositions containing them
09/12/1995CA2144231A1 5-vinyl- and 5-ethinyl-quinolone- and -naphthyridone-carboxylic acids
09/12/1995CA2143519A1 Beta-lactams
09/12/1995CA2143462A1 Method for slowing progression of coronary artery atherosclerosis employing pravastatin
09/12/1995CA2039197C Pharmaceutic formulation for the treatment of alcoholism
09/12/1995CA1336978C Bisphosphonates
09/12/1995CA1336977C Azetidinone intermediates to carbacephalosporins and process
09/12/1995CA1336975C Benzazepine and benzothiazepine derivatives
09/12/1995CA1336964C Antiinflammatory carbinoloimidazoles
09/12/1995CA1336963C Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion
09/12/1995CA1336962C Method for treating alcoholism by extinguishing the alcohol-drinking response
09/12/1995CA1336961C Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
09/12/1995CA1336960C Inhibition of serine proteases in the treatment of degenerative disorders
09/12/1995CA1336959C Uricosuric composition
09/12/1995CA1336958C Peroral preparation of acid-unstable compound
09/12/1995CA1336955C Respiratory syncytial virus: vaccines and diagnostic assays
09/12/1995CA1336953C Method of preventing or reducing adverse reactions to protamine using a thromboxane a _receptor antagonist
09/11/1995CA2144019A1 Tetrazolyphenyl pivalate derivatives and medicinal composition containing the same as effective component
09/11/1995CA2143013A1 6,7-epoxy paclitaxels
09/08/1995WO1995023870A1 Novel process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of streptomyces sp. p 6621 ferm p 2804
09/08/1995WO1995023855A2 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995WO1995023809A1 Antithrombotic agents
09/08/1995WO1995023808A1 3''-desmethoxy derivatives of erythromycin and azithromycin
09/08/1995WO1995023806A2 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
09/08/1995WO1995023799A1 Process for the preparation of an indazole-3-carboxamide derivative
09/08/1995WO1995023798A1 Prodrugs of morpholine tachykinin receptor antagonists
09/08/1995WO1995023797A1 Process for making an epoxide
09/08/1995WO1995023792A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same
09/08/1995WO1995023791A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same
09/08/1995WO1995023790A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
09/08/1995WO1995023789A1 Bicyclic carbamates as leukotriene d4 antagonists
09/08/1995WO1995023783A1 Ketopanthenol with acetylating properties
09/08/1995WO1995023782A1 Calcium ketopantothenate with acetylating properties
09/08/1995WO1995023613A1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION
09/08/1995WO1995023610A1 Pharmaceutical composition containing thymoctonan and azt
09/08/1995WO1995023609A1 Antithrombotic agents
09/08/1995WO1995023608A1 Antithrombotic agents
09/08/1995WO1995023607A1 Antibacterial agent containing tea extract or active fraction thereof and beta-lactam antibiotic
09/08/1995WO1995023605A1 Method for treating and inhibiting gastric and duodenal ulcers
09/08/1995WO1995023604A1 Cell growth stimulating compositions containing aloesin
09/08/1995WO1995023603A1 Use of 2-amino-4,5,7,8-tetrahydro-6h-thiazolo[5,4-d]azepines substituted in position 6 as medicaments having an anti-depressant effect, and preparation thereof
09/08/1995WO1995023602A1 Antitussive composition containing an antitussive and benzydamine
09/08/1995WO1995023601A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
09/08/1995WO1995023600A1 Sublingual or buccal pharmaceutical composition
09/08/1995WO1995023595A1 Concentrated acetaminophen solution compositions
09/08/1995WO1995023593A1 Controlled release oxybutynin formulations
09/08/1995WO1995023588A1 Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles
09/08/1995WO1995023587A1 Anti-acne compositions
09/08/1995WO1995021927A3 Targeting gene therapy
09/08/1995CA2184707A1 Animals with targeted gene disruption
09/08/1995CA2184619A1 Novel process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of streptomyces sp. p 6621 ferm p 2804
09/08/1995CA2184580A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995CA2184479A1 Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles
09/08/1995CA2184378A1 Anti-acne compositions
09/08/1995CA2184188A1 Antithrombotic agents
09/08/1995CA2184112A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same
09/08/1995CA2184111A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same
09/08/1995CA2183754A1 Calcium ketopantothenate with acetylating properties
09/08/1995CA2183752A1 Ketopanthenol with acetylating properties
09/08/1995CA2183464A1 Antithrombotic agents
09/08/1995CA2183329A1 Method for treating and inhibiting gastric and duodenal ulcers
09/08/1995CA2180141A1 Antithrombotic agents
09/08/1995CA2160250A1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
09/08/1995CA2160248A1 Pharmaceutical composition containing thymoctonan and azt
09/08/1995CA2122509A1 Potentiation of bioreductive agents
09/07/1995DE4407141A1 Verwendung von in 6-Stellung substituierten 2-Amino-4,5,7,8-tetrahydro-6H-thiazolo[5,4-d] azepinen als Arzneimittel mit antidepressiver Wirkung und deren Herstellung Use of substituted in the 6-position of 2-amino-4,5,7,8-tetrahydro-6H-thiazolo [5,4-d] azepines as a medicament having antidepressant activity and their preparation
09/06/1995EP0670330A1 Long-chain alkylamides of aminoacids and peptides with antiproliferative and antiinflammatory properties
09/06/1995EP0670328A1 Therapeutic nucleosides
09/06/1995EP0670327A1 Crystalline maltotetraosyl glucoside, and its production and use
09/06/1995EP0670318A2 Acetamides with analgesic and neuroprotective activity
09/06/1995EP0670315A1 Triazole oxime derivatives having antimycotic acitivity
1 ... 6986 6987 6988 6989 6990 6991 6992 6993 6994 6995 6996 6997 6998 6999 7000 7001 7002 7003 7004 7005 7006 ... 7860